Artwork

Content provided by Core IM Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Core IM Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

#144 RSV & What Makes Vaccine Trials Different: Beyond Journal Club on the RENOIR and AReSVi Trials

23:28
 
Share
 

Manage episode 398442015 series 1887065
Content provided by Core IM Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Core IM Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group.

Sponsor: Pathway FREE evidence-based clinical decision support app. Guideline summaries, interactive algorithms, landmark trials & more

Show Notes & Transcript

Time Stamps

  • 02:30 Epidemiology of RSV
  • 03:46 Development of RSV vaccine
  • 05:55 Vaccine trial design
  • 12:22 ARESVI and RENOIR Trials
  • 18:18 Who should we recommend the RSV vaccine to?
  • 19:50 What don’t we know?


Tags: IMCore, CoreIM, primary care, infectious disease, nurse practitioner, pharmacist, physician assistant


Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

218 episodes

Artwork
iconShare
 
Manage episode 398442015 series 1887065
Content provided by Core IM Team. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by Core IM Team or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.

How do you counsel patients eligible for the RSV vaccines? What do the results of the RENOIR and AReSVi trials tell us and how do they compare? How should we interpret vaccine trials in the first place? Tune in to the fourth episode of Beyond Journal Club, a new series brought to you by Core IM in collaboration with NEJM Group.

Sponsor: Pathway FREE evidence-based clinical decision support app. Guideline summaries, interactive algorithms, landmark trials & more

Show Notes & Transcript

Time Stamps

  • 02:30 Epidemiology of RSV
  • 03:46 Development of RSV vaccine
  • 05:55 Vaccine trial design
  • 12:22 ARESVI and RENOIR Trials
  • 18:18 Who should we recommend the RSV vaccine to?
  • 19:50 What don’t we know?


Tags: IMCore, CoreIM, primary care, infectious disease, nurse practitioner, pharmacist, physician assistant


Find the best disability insurance for you: https://www.patternlife.com/disability-insurance?campid=497840
Advertising Inquiries: https://redcircle.com/brands
Privacy & Opt-Out: https://redcircle.com/privacy
  continue reading

218 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide